课题基金 / 基金详情

CELLS FOR DETECTING NEGATIVE-STRAND RNA VIRUSES

CELLS FOR DETECTING NEGATIVE-STRAND RNA VIRUSES
用于检测负链 RNA 病毒的细胞
批准号:
6141327
负责人:
Paul David Olivo
金额:
$9.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-01 至 2000-12-31

项目摘要

项目成果

Paul David Olivo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of this proposal is to develop the commercial potential of a bioassay to detect and guantitate negative-strand RNA viruses. The basis of this bioassay, which has been prototyped with respiratory syncytial virus, is infection-dependent expression of a reporter gene from an artificial viral genome present within the cytoplasm of transformed cells. Negative-strand RNA viruses include some of the most notorious human pathogens and cause significant worldwide morbidity and mortality due to severe respiratory disease, hemorrhagic fever syndromes, etc. Unfortunately very few therapeutic agents and vaccines are available to control these viruses. Efforts to find new antiviral agents and to develop vaccines will require methods to detect and guantitate infectious virus which are amenable to highthroughput assays. Since all viruses are obligate intracellular microbes, any method to detect infectious virus and to determine the effects of various agents on viral replication must be based on cell culture. Traditional cellculture assays even when combined with immunoassays or nucleic acid-based methods are generally labor intensive and difficult to streamline. Significant advances have been made in identifying the cisacting elements and trans-acting factors involved in replication of many pathogenic negative-strand RNA viruses. The technology on which this proposal is based uses this information to develop cell lines in which the expression of an easily measurable enzyme is dependent on infection with a specific virus. PROPOSED COMMERCIAL APPLICATION: Negative-strand RNA viruses include some of the most important emerging human pathogens. The novel bioassay to detect and quantitate many of these viruses described in this proposal will promote efforts to find new antiviral agents and develop vaccines to control these viruses. Also, if sensitivity and specificty issues are addressed, it has the potential to facilitate diagnosis of these viruses in clinical virology laboratories.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutics for Ebola virus
  • 批准号:
    6998649
  • 项目类别:
  • 资助金额:
    $135.0万
  • 财政年份:
    2005
  • 负责人:
    Paul David Olivo
  • 依托单位:
Molecular tools for Bunyavirus antiviral screening
  • 批准号:
    6736739
  • 项目类别:
  • 资助金额:
    $32.73万
  • 财政年份:
    2004
  • 负责人:
    Paul David Olivo
  • 依托单位:
Replicon-based screening for inhibitors of alphaviruses
  • 批准号:
    6911672
  • 项目类别:
  • 资助金额:
    $47.5万
  • 财政年份:
    2004
  • 负责人:
    Paul David Olivo
  • 依托单位:
Transgenic indicator cells for influenza virus
  • 批准号:
    7013204
  • 项目类别:
  • 资助金额:
    $27.29万
  • 财政年份:
    2004
  • 负责人:
    Paul David Olivo
  • 依托单位:
海外基金